Drug and gene delivery across the blood-brain barrier with focused ultrasound

Journal of Controlled Release

Volumn 219, Issue , 2015, Pages 61-75

  Timbie, Kelsie F ^a   Mead, Brian P ^a   Price, Richard J ^a  

^a University of Virginia   (United States)

Author keywords

Bloodbrain barrier; CNS drug delivery; Focused ultrasound; Nanoparticles

Indexed keywords

BLOOD; CONTROLLED DRUG DELIVERY; GENE TRANSFER; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; NEURODEGENERATIVE DISEASES; ULTRASONICS;

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEMS; CNS DRUG DELIVERY; FOCUSED ULTRASOUND; LOCALIZED DELIVERY; PSYCHIATRIC DISORDERS; SURGICAL PROCEDURES; TECHNOLOGICAL ADVANCES;

TARGETED DRUG DELIVERY;

DRUG VEHICLE; LIPOSOME; PARVOVIRUS VECTOR; PLASMID VECTOR; POLYMER; NANOPARTICLE;

ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; FOCUSED ULTRASOUND; GENE DELIVERY SYSTEM; GENE THERAPY; HUMAN; LIPOSOMAL DELIVERY; LIPOSOMAL GENE DELIVERY SYSTEM; MICROBUBBLE; NAKED PLASMID DELIVERY; NANOPHARMACEUTICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUSCEPTIBILITY WEIGHTED IMAGING; ULTRASOUND; ANIMAL; CHEMISTRY; GENE TRANSFER; METABOLISM;

ANIMALS; BLOOD-BRAIN BARRIER; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; NANOPARTICLES; POLYMERS; ULTRASONIC WAVES;

EID: 84947485225     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.08.059     Document Type: Article

References (208)

1. S. Puhalla, W. Elmquist, D. Freyer, L. Kleinberg, C. Adkins, P. Lockman, and et al. Unsanctifying the sanctuary: challenges and opportunities with brain metastases Neuro-Oncology 17 2015 639 651 10.1093/neuonc/nov023
2. M.D. Prados, S.A. Byron, N.L. Tran, J.J. Phillips, A.M. Molinaro, K.L. Ligon, and et al. Toward precision medicine in glioblastoma: the promise and the challenges Neuro-Oncology 2015 10.1093/neuonc/nov031
3. Neurological Disorders: Public Health Challenges 2006
4. Substance Abuse and Mental Health Services Administration Results From the 2012 National Survey on Drug Use and Health: Summary of National Findings http://store.samhsa.gov/home 2013
5. W.F. Stewart, J.A. Ricci, E. Chee, S.R. Hahn, and D. Morganstein Cost of lost productive work time among US workers with depression J. Am. Med. Assoc. 289 2003 3135 3144 10.1001/jama.289.23.3135
6. W.M. Pardridge The blood-brain barrier: bottleneck in brain drug development NeuroRx 2 2005 3 14 10.1602/neurorx.2.1.3
7. H.-C. Bauer, I.A. Krizbai, H. Bauer, and A. Traweger "You Shall Not Pass" - tight junctions of the blood brain barrier Front. Neurosci. 8 2014 392 10.3389/fnins.2014.00392
8. W.M. Pardridge, and R.J. Boado Reengineering Biopharmaceuticals for Targeted Delivery Across the Blood-Brain Barrier 1st ed. 2012 Elsevier Inc. 10.1016/B978-0-12-396962-0.00011-2
9. D. Deleu, M.G. Northway, and Y. Hanssens Clinicalpharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease Clin. Pharmacokinet. 41 2002 261 309 10.2165/00003088-200241040-00003
10. R.R. Lonser, M. Sarntinoranont, P.F. Morrison, and E.H. Oldfield Convection-enhanced delivery to the central nervous system J. Neurosurg. 122 2015 697 706 10.3171/2014.10.JNS14229 (Disclosure)
11. P.F. Morrison Distributed models of drug kinetics Princ. Clin. Pharmacol. 2007 107 128 10.1016/B978-012369417-1/50049-3
12. R.H. Bobo, D.W. Laske, A. Akbasak, P.F. Morrisont, R.L. Dedrickt, and E.H. Oldfield Convection-enhanced delivery of macromolecules in the brain 91 1994 2076 2080
13. W.J. Marks, R.T. Bartus, J. Siffert, C.S. Davis, A. Lozano, N. Boulis, and et al. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial Lancet Neurol. 9 2010 1164 1172 10.1016/S1474-4422(10)70254-4
14. W.J. Marks, J.L. Ostrem, L. Verhagen, P.A. Starr, P.S. Larson, R.A. Bakay, and et al. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial Lancet Neurol. 7 2008 400 408 10.1016/S1474-4422(08)70065-6
15. S. Ramaswamy, J.L. McBride, I. Han, E.M. Berry-Kravis, L. Zhou, C.D. Herzog, and et al. Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease Neurobiol. Dis. 34 2009 40 50 10.1016/j.nbd.2008.12.005
16. M. Gasmi, E.P. Brandon, C.D. Herzog, A. Wilson, K.M. Bishop, E.K. Hofer, and et al. AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease Neurobiol. Dis. 27 2007 67 76 10.1016/j.nbd.2007.04.003
17. X. Ren, T. Zhang, X. Gong, G. Hu, W. Ding, and X. Wang AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model Exp. Neurol. 248 2013 148 156 10.1016/j.expneurol.2013.06.002
18. G.S. Gonzales-Portillo, P.R. Sanberg, M. Franzblau, C. Gonzales-Portillo, T. Diamandis, M. Staples, and et al. Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier Cell Transplant. 23 2014 531 539 10.3727/096368914X678337
19. H.J. Lee, Y. Zhang, and W.M. Pardridge Blood-brain barrier disruption following the internal carotid arterial perfusion of alkyl glycerols J. Drug Target. 10 2002 463 467 10.1080/1061186021000038337
20. A.K. Bhattacharjee, T. Kondoh, T. Nagashima, M. Ikeda, K. Ehara, and N. Tamaki Quantitative analysis of papaverine-mediated blood-brain barrier disruption in rats Biochem. Biophys. Res. Commun. 289 2001 548 552 10.1006/bbrc.2001.6029
21. K.L. Black, T. Cloughesy, S.C. Huang, Y.P. Gobin, Y. Zhou, J. Grous, and et al. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas 1997 10.3171/jns.1997.86.4.0603
22. J.J. Lochhead, and R.G. Thorne Intranasal delivery of biologics to the central nervous system Adv. Drug Deliv. Rev. 64 2012 614 628 10.1016/j.addr.2011.11.002
23. H.R. Costantino, L. Illum, G. Brandt, P.H. Johnson, and S.C. Quay Intranasal delivery: physicochemical and therapeutic aspects Int. J. Pharm. 337 2007 1 24 10.1016/j.ijpharm.2007.03.025
24. M. Ikeda, A.K. Bhattacharjee, T. Kondoh, T. Nagashima, and N. Tamaki Synergistic effect of cold mannitol and Na(+)/Ca(2 +) exchange blocker on blood-brain barrier opening Biochem. Biophys. Res. Commun. 291 2002 669 674 10.1006/bbrc.2002.6495
25. E. Zylber-Katz, J.M. Gomori, A. Schwartz, A. Lossos, F. Bokstein, and T. Siegal Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma Clin. Pharmacol. Ther. 67 2000 631 641 10.1067/mcp.2000.106932
26. N. Lipsman, M.L. Schwartz, Y. Huang, L. Lee, T. Sankar, M. Chapman, and et al. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study Lancet Neurol. 12 2013 462 468 10.1016/S1474-4422(13)70048-6
27. W.J. Elias, D. Huss, T. Voss, J. Loomba, M. Khaled, E. Zadicario, and et al. A pilot study of focused ultrasound thalamotomy for essential tremor N. Engl. J. Med. 369 2013 640 648 10.1056/NEJMoa1300962
28. R. Dallapiazza, M.S. McKisic, B. Shah, and W.J. Elias Neuromodulation for movement disorders Neurosurg. Clin. N. Am. 25 2014 47 58 10.1016/j.nec.2013.08.002
29. P.P. Dobrakowski, A.K. Machowska-Majchrzak, B. Labuz-Roszak, K.G. Majchrzak, E. Kluczewska, and K.B. Pierzchała MR-guided focused ultrasound: a new generation treatment of Parkinson's disease, essential tremor and neuropathic pain Interv. Neuroradiol 20 2014 275 282 (http://www.ncbi.nlm.nih.gov/pubmed/24976088, accessed May 18, 2015)
30. K. Hynynen, and N. Mcdannold Imaging - Guided Focal Opening of the Blood-Brain Barrier in Rabbits 1 2001
31. K. Hynynen, N. McDannold, N. Vykhodtseva, and F.A. Jolesz Non-invasive opening of BBB by focused ultrasound Acta Neurochir. Suppl. 86 2003 555 558
32. N. McDannold, N. Vykhodtseva, S. Raymond, F.A. Jolesz, and K. Hynynen MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits Ultrasound Med. Biol. 31 2005 1527 1537 10.1016/j.ultrasmedbio.2005.07.010
33. V.M. Runge, J.A. Clanton, A.C. Price, C.J. Wehr, W.A. Herzer, C.L. Partain, and et al. The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption Magn. Reson. Imaging 3 1985 43 55 10.1016/0730-725X(85)90008-6
34. H.L. Liu, Y.Y. Wai, W.S. Chen, J.C. Chen, P.H. Hsu, X.Y. Wu, and et al. Hemorrhage detection during focused-ultrasound induced blood-brain-barrier opening by using susceptibility-weighted magnetic resonance imaging Ultrasound Med. Biol. 34 2008 598 606 10.1016/j.ultrasmedbio.2008.01.011
35. A.L. Cheng, S. Batool, C.R. McCreary, M.L. Lauzon, R. Frayne, M. Goyal, and et al. Susceptibility-weighted imaging is more reliable than T2∗-weighted gradient-recalled echo mri for detecting microbleeds Stroke 44 2013 2782 2786 10.1161/STROKEAHA.113.002267
36. W. Fry, F. Fry, R. Meyers, and R.C. Eggleton The use of ultrasound in neurosurgery Third Int. Conf. Med. Electron 1960 (http://www.brl.uiuc.edu/Publications/1960/Fry-TICME-453-1960.pdf, accessed May 12, 2015)
37. K. Hynynen, and F.A. Jolesz Demonstration of potential noninvasive ultrasound brain therapy through an intact skull Ultrasound Med. Biol. 24 1998 275 283 10.1016/S0301-5629(97)00269-X
38. J.A. Rooney Shear as a mechanism for sonically induced biological effects J. Acoust. Soc. Am. 52 1972 1718 1724 (http://www.ncbi.nlm.nih.gov/pubmed/4641374)
39. B.J. Davidson, and N. Riley Microstreaming East 15 1971 217 233
40. H. Chen, W. Kreider, A.A. Brayman, M.R. Bailey, and T.J. Matula Blood vessel deformations on microsecond time scales by ultrasonic cavitation Phys. Rev. Lett. 106 2011 034301 (http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3087441&tool=pmcentrez&rendertype=abstract, accessed May 21, 2015)
41. J. Wu, J.P. Ross, and J.-F. Chiu Reparable sonoporation generated by microstreaming J. Acoust. Soc. Am. 111 2002 1460 10.1121/1.1420389
42. L.J.M. Juffermans, A. van Dijk, C.A.M. Jongenelen, B. Drukarch, A. Reijerkerk, H.E. de Vries, and et al. Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells Ultrasound Med. Biol. 35 2009 1917 1927 10.1016/j.ultrasmedbio.2009.06.1091
43. N. Sheikov, N. McDannold, S. Sharma, and K. Hynynen Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium Ultrasound Med. Biol. 34 2008 1093 1104 10.1016/j.ultrasmedbio.2007.12.015
44. J. Deng, Q. Huang, F. Wang, Y. Liu, Z. Wang, Z. Wang, and et al. The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles J. Mol. Neurosci. 46 2012 677 687 10.1007/s12031-011-9629-9
45. C. Xia, Z. Zhang, Y. Xue, P. Wang, and Y. Liu Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin J. Neuro-Oncol. 94 2009 41 50 10.1007/s11060-009-9812-9
46. B.D.M. Meijering, L.J.M. Juffermans, A. van Wamel, R.H. Henning, I.S. Zuhorn, M. Emmer, and et al. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation Circ. Res. 104 2009 679 687 10.1161/CIRCRESAHA.108.183806
47. T. Nhan, A. Burgess, E.E. Cho, B. Stefanovic, L. Lilge, and K. Hynynen Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy J. Control. Release 172 2013 274 280 (http://www.sciencedirect.com/science/article/pii/S0168365913004987, accessed October 28, 2013)
48. H. Chen, and E.E. Konofagou The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure J. Cereb. Blood Flow Metab. 34 2014 1197 1204 10.1038/jcbfm.2014.71
49. E.E. Cho, J. Drazic, M. Ganguly, B. Stefanovic, and K. Hynynen Two-photon fluorescence microscopy study of cerebrovascular dynamics in ultrasound-induced blood-brain barrier opening J. Cereb. Blood Flow Metab. 31 2011 1852 1862 10.1038/jcbfm.2011.59
50. N. McDannold, N. Vykhodtseva, and K. Hynynen Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity Phys. Med. Biol. 51 2006 793 807 10.1088/0031-9155/51/4/003
51. G. Samiotaki, F. Vlachos, Y.S. Tung, J. Feshitan, M. Borden, and E.E. Konofagou Pressure and microbubble size dependence study of focused ultrasound-induced blood-brain barrier opening reversibility in vivo AIP Conf. Proc. 1481 2012 300 306 10.1063/1.4757352
52. J. Park, Y. Zhang, N. Vykhodtseva, F.A. Jolesz, and N.J. McDannold The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound J. Control. Release 162 2012 134 142 10.1016/j.jconrel.2012.06.012
53. G.P. Howles, K.F. Bing, Y. Qi, S.J. Rosenzweig, K.R. Nightingale, and G.A. Johnson Contrast-enhanced in vivo magnetic resonance microscopy of the mouse brain enabled by noninvasive opening of the blood-brain barrier with ultrasound Magn. Reson. Med. 64 2010 995 1004 10.1002/mrm.22411
54. N. McDannold, C.D. Arvanitis, N. Vykhodtseva, and M.S. Livingstone Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques Cancer Res. 72 2012 3652 3663 10.1158/0008-5472.CAN-12-0128
55. M.E. Downs, A. Buch, C. Sierra, M.E. Karakatsani, S. Chen, E.E. Konofagou, and et al. Long-term safety of repeated blood-brain barrier opening via focused ultrasound with microbubbles in non-human primates performing a cognitive task PLoS One 10 2015 e0125911 10.1371/journal.pone.0125911
56. K. Hynynen, N. McDannold, N.A. Sheikov, F.A. Jolesz, and N. Vykhodtseva Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications NeuroImage 24 2005 12 20 10.1016/j.neuroimage.2004.06.046
57. P.J. Rauch, H.S. Park, J.P.S. Knisely, V.L. Chiang, and A.O. Vortmeyer Delayed radiation-induced vasculitic leukoencephalopathy Int. J. Radiat. Oncol. Biol. Phys. 83 2012 369 375 10.1016/j.ijrobp.2011.06.1982
58. B.C. Oh, P.G. Pagnini, M.Y. Wang, C.Y. Liu, P.E. Kim, C. Yu, and et al. Stereotactic radiosurgery: adjacent tissue injury and response after high-dose single fraction radiation: part I - histology, imaging, and molecular events Neurosurgery 60 2007 31 44 10.1227/01.NEU.0000249191.23162.D2
59. M.A. O'Reilly, and K. Hynynen Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller Radiology 263 2012 96 106 10.1148/radiol.11111417
60. Y.-S. Tung, F. Vlachos, J.J. Choi, T. Deffieux, K. Selert, and E.E. Konofagou In vivo transcranial cavitation threshold detection during ultrasound-induced blood-brain barrier opening in mice Phys. Med. Biol. 55 2010 6141 6155 10.1088/0031-9155/55/20/007
61. S. Samuel, M.A. Cooper, J.L. Bull, J.B. Fowlkes, and D.L. Miller An ex vivo study of the correlation between acoustic emission and microvascular damage Ultrasound Med. Biol. 35 2009 1574 1586 10.1016/j.ultrasmedbio.2009.04.013
62. S.I. Madanshetty, R.A. Roy, and R.E. Apfel Acoustic microcavitation: its active and passive acoustic detection J. Acoust. Soc. Am. 90 1991 1515 1526
63. V.I. Ilyichev, V.L. Koretz, and N.P. Melnikov Spectral characteristics of acoustic cavitation Ultrasonics 27 1989 357 361 10.1016/0041-624X(89)90034-6
64. T.G. Leighton The Acoustic Bubble J. Acoust. Soc. Am. 96 1994 2616 10.1121/1.410082
65. C.D. Arvanitis, M.S. Livingstone, N. Vykhodtseva, and N. McDannold Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring PLoS One 7 2012 10.1371/journal.pone.0045783
66. S.Y. Wu, Y.S. Tung, F. Marquet, M. Downs, C. Sanchez, C. Chen, and et al. Transcranial cavitation detection in primates during blood-brain barrier opening-a performance assessment study IEEE Trans. Ultrason. Ferroelectr. Freq. Control 61 2014 966 978 10.1109/TUFFC.2014.2992
67. W.Y. Chai, P.C. Chu, M.Y. Tsai, Y.C. Lin, J.J. Wang, K.C. Wei, and et al. Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery J. Control. Release 192 2014 1 9 10.1016/j.jconrel.2014.06.023
68. J.F. Jordão, E. Thévenot, K. Markham-Coultes, T. Scarcelli, Y.-Q. Weng, K. Xhima, and et al. Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound Exp. Neurol. 248 2013 16 29 10.1016/j.expneurol.2013.05.008
69. G. Leinenga, and J. Götz Scanning ultrasound removes amyloid-b and restores memory in an Alzheimer's disease mouse model Sci. Transl. Med. 7 2015
70. N. McDannold, C.D. Arvanitis, N. Vykhodtseva, and M.S. Livingstone Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques Cancer Res. 2012 10.1158/0008-5472.CAN-12-0128
71. C.W. Burke, A.L. Klibanov, J.P. Sheehan, and R.J. Price Inhibition of glioma growth by microbubble activation in a subcutaneous model using low duty cycle ultrasound without significant heating J. Neurosurg. 114 2011 1654 1661 10.3171/2010.11.JNS101201
72. T. Scarcelli, J.F. Jordão, M.A. O'Reilly, N. Ellens, K. Hynynen, and I. Aubert Stimulation of hippocampal neurogenesis by transcranial focused ultrasound and microbubbles in adult mice Brain Stimul. 7 2014 304 307 10.1016/j.brs.2013.12.012
73. Y. Tufail, A. Matyushov, N. Baldwin, M.L. Tauchmann, J. Georges, A. Yoshihiro, and et al. Transcranial pulsed ultrasound stimulates intact brain circuits Neuron 66 2010 681 694 10.1016/j.neuron.2010.05.008
74. S. Jalali, Y. Huang, D.J. Dumont, and K. Hynynen Focused ultrasound-mediated bbb disruption is associated with an increase in activation of AKT: experimental study in rats BMC Neurol. 10 2010 114 10.1186/1471-2377-10-114
75. S.-J. Tsai Transcranial focused ultrasound as a possible treatment for major depression Med. Hypotheses 84 2015 381 383 10.1016/j.mehy.2015.01.030
76. W.J. Tyler, Y. Tufail, M. Finsterwald, M.L. Tauchmann, E.J. Olson, and C. Majestic Remote excitation of neuronal circuits using low-intensity, low-frequency ultrasound PLoS One 3 2008 e3511 10.1371/journal.pone.0003511
77. T. Deffieux, Y. Younan, N. Wattiez, M. Tanter, P. Pouget, and J.-F. Aubry Low-intensity focused ultrasound modulates monkey visuomotor behavior Curr. Biol. 23 2013 2430 2433 10.1016/j.cub.2013.10.029
78. H. Kim, S.J. Taghados, K. Fischer, L.S. Maeng, S. Park, and S.S. Yoo Noninvasive transcranial stimulation of rat abducens nerve by focused ultrasound Ultrasound Med. Biol. 38 2012 1568 1575 10.1016/j.ultrasmedbio.2012.04.023
79. S.S. Yoo, A. Bystritsky, J.H. Lee, Y. Zhang, K. Fischer, B.K. Min, and et al. Focused ultrasound modulates region-specific brain activity NeuroImage 56 2011 1267 1275 10.1016/j.neuroimage.2011.02.058
80. W. Legon, A. Rowlands, A. Opitz, T.F. Sato, and W.J. Tyler Pulsed ultrasound differentially stimulates somatosensory circuits in humans as indicated by EEG and fMRI PLoS One 7 2012 10.1371/journal.pone.0051177
81. W. Lee, H. Kim, Y. Jung, I.-U. Song, Y.A. Chung, and S.-S. Yoo Image-guided transcranial focused ultrasound stimulates human primary somatosensory cortex Sci. Rep. 5 2015 8743 10.1038/srep08743
82. M. Aryal, N. Vykhodtseva, Y.-Z. Zhang, J. Park, and N. McDannold Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model J. Control. Release 169 2013 103 111 10.1016/j.jconrel.2013.04.007
83. H.-L. Liu, C.-Y. Huang, J.-Y. Chen, H.-Y.J. Wang, P.-Y. Chen, and K.-C. Wei Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment PLoS One 9 2014 e114311 10.1371/journal.pone.0114311
84. L.H. Treat, N. McDannold, N. Vykhodtseva, Y. Zhang, K. Tam, and K. Hynynen Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound Int. J. Cancer 121 2007 901 907 10.1002/ijc.22732
85. J.F. Jordão, C.A. Ayala-Grosso, K. Markham, Y. Huang, R. Chopra, J. McLaurin, and et al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease PLoS One 5 2010 e10549 10.1371/journal.pone.0010549
86. G. Samiotaki, C. Acosta, S. Wang, and E.E. Konofagou Enhanced delivery and bioactivity of the neurturin neurotrophic factor through focused ultrasound-mediated blood-brain barrier opening in vivo J. Cereb. Blood Flow Metab. 35 2015 611 622 10.1038/jcbfm.2014.236
87. M. Aryal, J. Park, N. Vykhodtseva, Y.-Z. Zhang, and N. McDannold Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model Phys. Med. Biol. 60 2015 2511 2527 10.1088/0031-9155/60/6/2511
88. C.-H. Fan, C.-Y. Ting, H.-L. Liu, C.-Y. Huang, H.-Y. Hsieh, T.-C. Yen, and et al. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment Biomaterials 34 2013 2142 2155 10.1016/j.biomaterials.2012.11.048
89. F.-Y. Yang, T.-T. Wong, M.-C. Teng, R.-S. Liu, M. Lu, H.-F. Liang, and et al. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme J. Control. Release 160 2012 652 658 10.1016/j.jconrel.2012.02.023
90. R.D. Alkins, P.M. Brodersen, R.N.S. Sodhi, and K. Hynynen Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound Neuro-Oncology 15 2013 1225 1235 10.1093/neuonc/not052
91. K.-C. Wei, P.-C. Chu, H.-Y.J. Wang, C.-Y. Huang, P.-Y. Chen, H.-C. Tsai, and et al. Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study PLoS One 8 2013 e58995 10.1371/journal.pone.0058995
92. A. Malmström, B.H. Grønberg, C. Marosi, R. Stupp, D. Frappaz, H. Schultz, and et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial Lancet Oncol. 13 2012 916 926 10.1016/S1470-2045(12)70265-6
93. A. Darlix, C. Baumann, V. Lorgis, F. Ghiringhelli, M. Blonski, B. Chauffert, and et al. Prolonged administration of adjuvant temozolomide improves survival in adult patients with glioblastoma Anticancer Res. 33 2013 3467 3474 (http://www.ncbi.nlm.nih.gov/pubmed/23898121, accessed April 11, 2015)
94. M.R. Gilbert, M. Wang, K.D. Aldape, R. Stupp, M.E. Hegi, K.A. Jaeckle, and et al. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial J. Clin. Oncol. 31 2013 4085 4091 10.1200/JCO.2013.49.6968
95. A.D. Norden, G.J. Lesser, J. Drappatz, K.L. Ligon, S.N. Hammond, E.Q. Lee, and et al. Phase 2 study of dose-intense temozolomide in recurrent glioblastoma Neuro-Oncology 15 2013 930 935 10.1093/neuonc/not040
96. M. Westphal, D.C. Hilt, E. Bortey, P. Delavault, R. Olivares, P.C. Warnke, and et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro-Oncology 5 2003 79 88 10.1215/S1522-8517-02-00023-6
97. S. Gururangan, L. Cokgor, J.N. Rich, S. Edwards, M.L. Affronti, J.A. Quinn, and et al. Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas Neuro-Oncology 3 2001 246 250 (http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1920622&tool=pmcentrez&rendertype=abstract, accessed April 11, 2015)
98. M. Westphal, Z. Ram, V. Riddle, D. Hilt, and E. Bortey Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial Acta Neurochir. 148 2006 269 275 10.1007/s00701-005-0707-z (discussion 275)
99. F.J. Attenello, D. Mukherjee, G. Datoo, M.J. McGirt, E. Bohan, J.D. Weingart, and et al. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience Ann. Surg. Oncol. 15 2008 2887 2893 10.1245/s10434-008-0048-2
100. H.-L. Liu, M.-Y. Hua, P.-Y. Chen, P.-C. Chu, C.-H. Pan, H.-W. Yang, and et al. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment Radiology 255 2010 415 425 10.1148/radiol.10090699
101. P. Hau, K. Fabel, U. Baumgart, P. Rümmele, O. Grauer, A. Bock, and et al. Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma Cancer 100 2004 1199 1207 10.1002/cncr.20073
102. Z. Kovacs, B. Werner, A. Rassi, J.O. Sass, E. Martin-Fiori, and M. Bernasconi Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models J. Control. Release 2014 10.1016/j.jconrel.2014.05.033
103. S. Savolainen, M. Kortesniemi, M. Timonen, V. Reijonen, L. Kuusela, J. Uusi-Simola, and et al. Boron neutron capture therapy (BNCT) in Finland: technological and physical prospects after 20 years of experiences Phys. Med. 29 2013 233 248 10.1016/j.ejmp.2012.04.008
104. L. Kankaanranta, T. Seppälä, H. Koivunoro, K. Saarilahti, T. Atula, J. Collan, and et al. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial Int. J. Radiat. Oncol. Biol. Phys. 82 2012 e67 e75 10.1016/j.ijrobp.2010.09.057
105. S.-I. Miyatake, S. Kawabata, K. Yokoyama, T. Kuroiwa, H. Michiue, Y. Sakurai, and et al. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas Appl. Radiat. Isot. 67 2009 S22 S24 10.1016/j.apradiso.2009.03.032
106. J.W. Hopewell, T. Gorlia, L. Pellettieri, V. Giusti, B. H-Stenstam, and K. Sköld Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential Appl. Radiat. Isot. 69 2011 1737 1740 10.1016/j.apradiso.2011.03.022
107. F.-Y. Yang, Y.-W. Chen, F.-I. Chou, S.-H. Yen, Y.-L. Lin, and T.-T. Wong Boron neutron capture therapy for glioblastoma multiforme: enhanced drug delivery and antitumor effect following blood-brain barrier disruption induced by focused ultrasound Future Oncol. 8 2012 1361 1369 10.2217/fon.12.118
108. F.-Y. Yang, Y.-L. Lin, F.-I. Chou, Y.-C. Lin, Y.-W. Hsueh Liu, L.-W. Chang, and et al. Pharmacokinetics of BPA in gliomas with ultrasound induced blood-brain barrier disruption as measured by microdialysis PLoS One 9 2014 e100104 10.1371/journal.pone.0100104
109. P. Kawalec, S. Łopuch, and A. Mikrut Effectiveness of targeted therapy in patients with previously untreated metastatic breast cancer: a systematic review and meta-analysis Clin. Breast Cancer 15 2015 90 100 10.1016/j.clbc.2014.10.006 (e1)
110. B. Spencer, and E. Masliah Immunotherapy for Alzheimer's disease: past, present and future Front. Aging Neurosci. 6 2014 114 10.3389/fnagi.2014.00114
111. N. Sheikov, N. McDannold, N. Vykhodtseva, F. Jolesz, and K. Hynynen Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles Ultrasound Med. Biol. 30 2004 979 989 10.1016/j.ultrasmedbio.2004.04.010
112. M. Kinoshita, N. McDannold, F.A. Jolesz, and K. Hynynen Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound Biochem. Biophys. Res. Commun. 340 2006 1085 1090 10.1016/j.bbrc.2005.12.112
113. S.B. Raymond, L.H. Treat, J.D. Dewey, N.J. McDannold, K. Hynynen, and B.J. Bacskai Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer's disease mouse models PLoS One 3 2008 e2175 10.1371/journal.pone.0002175
114. M. Kinoshita, N. McDannold, F.A. Jolesz, and K. Hynynen Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption Proc. Natl. Acad. Sci. U. S. A. 103 2006 11719 11723 10.1073/pnas.0604318103
115. A.O. Ahmed, A.M. Mantini, D.J. Fridberg, and P.F. Buckley Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysis Psychiatry Res. 226 2015 1 13 10.1016/j.psychres.2014.12.069
116. M. Kalia, J. Costa, and E. Silva Biomarkers of psychiatric diseases: current status and future prospects Metabolism 64 2015 10.1016/j.metabol.2014.10.026 (S11-5)
117. T.C. Theoharides, M. Athanassiou, S. Panagiotidou, and R. Doyle Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders J. Neuroimmunol. 279 2015 33 38 10.1016/j.jneuroim.2014.12.003
118. S.V. Hegarty, G.W. O'Keeffe, and A.M. Sullivan Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease Neural Regen. Res. 9 2014 1708 1711 10.4103/1673-5374.143410
119. B. Baseri, J.J. Choi, T. Deffieux, G. Samiotaki, Y.-S. Tung, O. Olumolade, and et al. Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles Phys. Med. Biol. 57 2012 N65 N81 10.1088/0031-9155/57/7/N65
120. F. Wang, Y. Shi, L. Lu, L. Liu, Y. Cai, H. Zheng, and et al. Targeted delivery of GDNF through the blood-brain barrier by MRI-guided focused ultrasound PLoS One 7 2012 e52925 10.1371/journal.pone.0052925
121. A.A. Thomas, C.W. Brennan, L.M. DeAngelis, and A.M. Omuro Emerging therapies for glioblastoma JAMA Neurol. 71 2014 1437 1444 10.1001/jamaneurol.2014.1701
122. L. Ampie, E.C. Woolf, and C. Dardis Immunotherapeutic advancements for glioblastoma Front. Oncol. 5 2015 12 10.3389/fonc.2015.00012
123. P.-Y. Chen, H.-Y. Hsieh, C.-Y. Huang, C.-Y. Lin, K.-C. Wei, and H.-L. Liu Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study J. Transl. Med. 13 2015 451 10.1186/s12967-015-0451-y
124. G. Bozzuto, and A. Molinari Liposomes as nanomedical devices Int. J. Nanomedicine 10 2015 975 999 10.2147/IJN.S68861
125. A. Mohan, S. Narayanan, S. Sethuraman, and U.M. Krishnan Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma Biomed. Res. Int. 2014 2014 424239 10.1155/2014/424239
126. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomedicine 1 2006 297 315 (http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2426795&tool=pmcentrez&rendertype=abstract, accessed February 12, 2015)
127. B.M. Dicheva, and G.A. Koning Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors Expert Opin. Drug Deliv. 11 2014 83 100 10.1517/17425247.2014.866650
128. G. Storm, F.H. Roerdink, P.A. Steerenberg, W.H. de Jong, and D.J. Crommelin Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model Cancer Res. 47 1987 3366 3372 (http://www.ncbi.nlm.nih.gov/pubmed/3581073, accessed April 10, 2015)
129. L.H. Treat, N. McDannold, Y. Zhang, N. Vykhodtseva, and K. Hynynen Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma Ultrasound Med. Biol. 38 2012 1716 1725 10.1016/j.ultrasmedbio.2012.04.015
130. F.-Y. Yang, H.-E. Wang, R.-S. Liu, M.-C. Teng, J.-J. Li, M. Lu, and et al. Pharmacokinetic analysis of 111In-labeled liposomal doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound PLoS One 7 2012 e45468 10.1371/journal.pone.0045468
131. M. Aryal, N. Vykhodtseva, Y.-Z. Zhang, and N. McDannold Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: A safety study J. Control. Release 204 2015 60 69 10.1016/j.jconrel.2015.02.033
132. N. Nomikou, P. Tiwari, T. Trehan, K. Gulati, and A.P. McHale Studies on neutral, cationic and biotinylated cationic microbubbles in enhancing ultrasound-mediated gene delivery in vitro and in vivo Acta Biomater. 8 2012 1273 1280 10.1016/j.actbio.2011.09.010
133. C.-H. Fan, H.-L. Liu, C.-Y. Ting, Y.-H. Lee, C.-Y. Huang, Y.-J. Ma, and et al. Submicron-bubble-enhanced focused ultrasound for blood-brain barrier disruption and improved CNS drug delivery PLoS One 9 2014 e96327 10.1371/journal.pone.0096327
134. C.-H. Fan, C.-Y. Ting, Y.-C. Chang, K.-C. Wei, H.-L. Liu, and C.-K. Yeh Drug-loaded bubbles with matched focused ultrasound excitation for concurrent blood-brain barrier opening and brain-tumor drug delivery Acta Biomater. 15 2015 89 101 10.1016/j.actbio.2014.12.026
135. C.-Y. Ting, C.-H. Fan, H.-L. Liu, C.-Y. Huang, H.-Y. Hsieh, T.-C. Yen, and et al. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment Biomaterials 33 2012 704 712 10.1016/j.biomaterials.2011.09.096
136. C.-H. Fan, C.-Y. Ting, H.-J. Lin, C.-H. Wang, H.-L. Liu, T.-C. Yen, and et al. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery Biomaterials 34 2013 3706 3715 10.1016/j.biomaterials.2013.01.099
137. J. Tereshchenko, A. Maddalena, M. Bähr, and S. Kügler Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease Neurobiol. Dis. 65 2014 35 42 10.1016/j.nbd.2014.01.009
138. S. Bäck, J. Peränen, E. Galli, P. Pulkkila, L. Lonka-Nevalaita, T. Tamminen, and et al. Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease Brain Behav. 3 2013 75 88 10.1002/brb3.117
139. T. Bjorklund, and J.H. Kordower Gene therapy for Parkinson's disease Mov. Disord. 25 Suppl. 1 2010 S161 S173 10.1002/mds.22785
140. P.A. LeWitt, A.R. Rezai, M.A. Leehey, S.G. Ojemann, A.W. Flaherty, E.N. Eskandar, and et al. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial Lancet Neurol. 10 2011 309 319 10.1016/S1474-4422(11)70039-4
141. S.R. Murphy, C.C.Y. Chang, G. Dogbevia, E.Y. Bryleva, Z. Bowen, M.T. Hasan, and et al. Acat1 knockdown gene therapy decreases amyloid-β in a mouse model of Alzheimer's disease 21 2013 1497 1506 10.1038/mt.2013.118
142. R.J. Mandel CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease Curr. Opin. Mol. Ther. 12 2010 240 247
143. V.J. Mccurdy, H.E. Rockwell, J.R. Arthur, A.M. Bradbury, A.K. Johnson, A.N. Randle, and et al. Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease Gene Ther. 22 2014 181 189 10.1038/gt.2014.108
144. M. Berry, L. Barrett, L. Seymour, A. Baird, and A. Logan Gene therapy for central nervous system repair Curr. Opin. Mol. Ther. 3 2001 338 349
145. H. Okura, C.A. Smith, and J.T. Rutka Gene therapy for malignant glioma Expert. Rev. Neurother. 6 2006 479 488 10.1586/14737175.6.4.479
146. K.S. Bankiewicz, J.L. Eberling, M. Kohutnicka, W. Jagust, P. Pivirotto, J. Bringas, and et al. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach Exp. Neurol. 164 2000 2 14 10.1006/exnr.2000.7408
147. T. Shahar, Z. Ram, and A.A. Kanner Convection-enhanced delivery catheter placements for high-grade gliomas: complications and pitfalls J. Neuro-Oncol. 107 2012 373 378 10.1007/s11060-011-0751-x
148. E. Allard, C. Passirani, and J.-P. Benoit Convection-enhanced delivery of nanocarriers for the treatment of brain tumors Biomaterials 30 2009 2302 2318 10.1016/j.biomaterials.2009.01.003
149. D. Omata, Y. Negishi, S. Hagiwara, S. Yamamura, Y. Endo-Takahashi, R. Suzuki, and et al. Bubble liposomes and ultrasound promoted endosomal escape of TAT-PEG liposomes as gene delivery carriers Mol. Pharm. 8 2011 2416 2423 10.1021/mp200353m
150. D. Omata, Y. Negishi, R. Suzuki, and Y. Oda Nonviral Gene Delivery Systems by the Combination of Bubble Liposomes and Ultrasound 2015 Elsevier Ltd. 10.1016/bs.adgen.2014.11.001
151. C.W. Burke, J.S. Suk, A.J. Kim, Y.-H.J. Hsiang, A.L. Klibanov, J. Hanes, and et al. Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles J. Control. Release 162 2012 414 421 10.1016/j.jconrel.2012.07.005
152. S. Xenariou, H.D. Liang, U. Griesenbach, J. Zhu, R. Farley, L. Somerton, and et al. Low-frequency ultrasound increases non-viral gene transfer to the mouse lung Acta Biochim. Biophys. Sin. (Shanghai) 42 2010 45 51 10.1093/abbs/gmp100
153. D.H. Park, B.K. Jung, Y.S. Lee, J.Y. Jang, M.K. Kim, J.K. Lee, and et al. Evaluation of in vivo antitumor effects of ANT2 shRNA delivered using PEI and ultrasound with microbubbles Gene Ther. 22 2015 325 332 10.1038/gt.2014.120
154. W. Xie, S. Liu, H. Su, Z. Wang, Y. Zheng, and Y. Fu Ultrasound microbubbles enhance recombinant adeno-associated virus vector delivery to retinal ganglion cells in vivo Acad. Radiol. 17 2010 1242 1248 10.1016/j.acra.2010.05.008
155. A.G. Sorace, J.M. Warram, M. Mahoney, K.R. Zinn, and K. Hoyt Enhancement of adenovirus delivery after ultrasound-stimulated therapy in a cancer model Ultrasound Med. Biol. 39 2013 2374 2381 10.1016/j.ultrasmedbio.2013.07.017
156. M. Konishi, K. Kawamoto, M. Izumikawa, H. Kuriyama, and T. Yamashita Gene transfer into guinea pig cochlea using adeno-associated virus vectors J. Gene Med. 10 2008 610 618 10.1002/jgm
157. J.P. Christiansen, B.A. French, A.L. Klibanov, S. Kaul, and J.R. Lindner Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles Ultrasound Med. Biol. 29 2003 1759 1767 10.1016/S0301-5629(03)00976-1
158. E. Thévenot, J.F. Jordão, M.A. O'Reilly, K. Markham, Y.-Q. Weng, K.D. Foust, and et al. Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound Hum. Gene Ther. 23 2012 1144 1155 10.1089/hum.2012.013
159. Q. Huang, J. Deng, Z. Xie, F. Wang, S. Chen, B. Lei, and et al. Effective gene transfer into central nervous system following ultrasound-microbubbles-induced opening of the blood-brain barrier Ultrasound Med. Biol. 38 2012 1234 1243 10.1016/j.ultrasmedbio.2012.02.019
160. Q. Huang, J. Deng, F. Wang, S. Chen, Y. Liu, Z. Wang, and et al. Targeted gene delivery to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption Exp. Neurol. 233 2012 350 356 10.1016/j.expneurol.2011.10.027
161. D.S. Wang, C. Panje, M.A. Pysz, R. Paulmurugan, J. Rosenberg, S.S. Gambhir, and et al. Cationic versus Neutral microbubbles for ultrasound-mediated gene delivery in cancer Radiology 264 2012 721 732 10.1148/radiol.12112368
162. C.W. Burke, Y.-H.J. Hsiang, E. Alexander, A.L. Kilbanov, and R.J. Price Covalently linking poly(lactic-co-glycolic acid) nanoparticles to microbubbles before intravenous injection improves their ultrasound-targeted delivery to skeletal muscle Small 7 2011 1227 1235 10.1002/smll.201001934
163. C.W. Burke, E. Alexander, K. Timbie, A.L. Kilbanov, and R.J. Price Ultrasound-activated agents comprised of 5FU-bearing nanoparticles bonded to microbubbles inhibit solid tumor growth and improve survival Mol. Ther. 22 2014 321 328 10.1038/mt.2013.259
164. S. Duque, B. Joussemet, C. Riviere, T. Marais, L. Dubreil, A.-M. Douar, and et al. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons Mol. Ther. 17 2009 1187 1196 10.1038/mt.2009.71
165. D. Weber-Adrian, E. Thévenot, M.A. O'Reilly, W. Oakden, M.K. Akens, N. Ellens, and et al. Gene delivery to the spinal cord using MRI-guided focused ultrasound Gene Ther. 2015 10.1038/gt.2015.25
166. S. Wang, O.O. Olumolade, T. Sun, G. Samiotaki, and E.E. Konofagou Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus Gene Ther. 2014 10.1038/gt.2014.91
167. A. Alonso, E. Reinz, B. Leuchs, J. Kleinschmidt, M. Fatar, B. Geers, and et al. Focal delivery of AAV2/1-transgenes into the rat brain by localized ultrasound-induced BBB opening Mol. Ther. Nucleic Acids 2 2013 e73 10.1038/mtna.2012.64
168. P.-H. Hsu, K.-C. Wei, C.-Y. Huang, C.-J. Wen, T.-C. Yen, C.-L. Liu, and et al. Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound PLoS One 8 2013 e57682 10.1371/journal.pone.0057682
169. M.G. Kaplitt, P. Leone, R.J. Samulski, X. Xiao, D.W. Pfaff, K.L. O'Malley, and et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain Nat. Genet. 8 1994 148 154 10.1038/ng1094-148
170. T.J. McCown, X. Xiao, J. Li, G.R. Breese, and R.J. Samulski Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector Brain Res. 713 1996 99 107 10.1016/0006-8993(95)01488-8
171. C. Summerford, and R.J. Samulski Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions J. Virol. 72 1998 1438 1445
172. F. Properzi, R. Lin, J. Kwok, M. Naidu, T.H. Van Kuppevelt, G.B. Ten Dam, and et al. Heparan sulphate proteoglycans in glia and in the normal and injured CNS: expression of sulphotransferases and changes in sulphation Eur. J. Neurosci. 27 2008 593 604 10.1111/j.1460-9568.2008.06042.x
173. C.S. Peden, C. Burger, N. Muzyczka, and R.J. Mandel Circulating anti-wild-type antibodies inhibit recombinant AAV2 gene transfer in the brain circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in J. Virol. 78 2004 6344 6359 10.1128/JVI.78.12.6344
174. R. Calcedo, and J.M. Wilson Humoral Immune response to AAV Front. Immunol. 4 2013 341 10.3389/fimmu.2013.00341
175. J. Wu, W. Zhao, L. Zhong, Z. Han, B. Li, W. Ma, and et al. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity Hum. Gene Ther. 18 2007 171 182 10.1089/hum.2006.088
176. A.Z. Wilczewska, K. Niemirowicz, K.H. Markiewicz, and H. Car Nanoparticles as drug delivery systems Pharmacol. Rep. 64 2012 1020 1037 10.1016/S1734-1140(12)70901-5
177. N.J. Boylan, J.S. Suk, S.K. Lai, R. Jelinek, M.P. Boyle, M.J. Cooper, and et al. Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation J. Control. Release 157 2012 72 79 10.1016/j.jconrel.2011.08.031
178. H.L. Wong, X.Y. Wu, and R. Bendayan Nanotechnological advances for the delivery of CNS therapeutics Adv. Drug Deliv. Rev. 2011 10.1016/j.addr.2011.10.007
179. J. Suh, K.-L. Choy, S.K. Lai, J.S. Suk, B.C. Tang, S. Prabhu, and et al. PEGylation of nanoparticles improves their cytoplasmic transport Int. J. Nanomedicine 2 2007 735 741 (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676827/, accessed April 4, 2012)
180. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A. Le Breton, and V. Préat PLGA-based nanoparticles: an overview of biomedical applications J. Control. Release 2012 10.1016/j.jconrel.2012.01.043
181. G. Tosi, B. Bortot, B. Ruozi, D. Dolcetta, M.A. Vandelli, F. Forni, and et al. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier Curr. Med. Chem. 20 2013 2212 2225 (http://www.ncbi.nlm.nih.gov/pubmed/23458620, accessed November 19, 2013)
182. A. Giteau, M.C. Venier-Julienne, A. Aubert-Pouëssel, and J.P. Benoit How to achieve sustained and complete protein release from PLGA-based microparticles? Int. J. Pharm. 350 2008 14 26 10.1016/j.ijpharm.2007.11.012
183. S. Dufort, L. Sancey, and J.-L. Coll Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution Adv. Drug Deliv. Rev. 64 2012 179 189 10.1016/j.addr.2011.09.009
184. A. Kumari, S.K. Yadav, and S.C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf. B: Biointerfaces 75 2010 1 18 10.1016/j.colsurfb.2009.09.001
185. J.C. Chappell, J. Song, C.W. Burke, A.L. Klibanov, and R.J. Price Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis Small 4 2008 1769 1777 10.1002/smll.200800806
186. A.V. Naumova, M. Modo, A. Moore, C.E. Murry, and J.A. Frank Clinical imaging in regenerative medicine Nat. Biotechnol. 32 2014 804 818 10.1038/nbt.2993
187. F. Chen, E.B. Ehlerding, and W. Cai Theranostic nanoparticles J. Nucl. Med. 55 2014 1919 1922 10.2967/jnumed.114.146019
188. S. Walia, and A. Acharya Silica micro/nanospheres for theranostics: from bimodal MRI and fluorescent imaging probes to cancer therapy Beilstein J. Nanotechnol. 6 2015 546 558 10.3762/bjnano.6.57
189. P. Mastorakos, C. Zhang, S. Berry, Y. Oh, S. Lee, C.G. Eberhart, and et al. Highly PEGylated DNA nanoparticles provide uniform and widespread gene transfer in the brain Adv. Healthcare Mater. 2015 10.1002/adhm.201400800 (n/a-n/a)
190. C.L. Grigsby, and K.W. Leong Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery J. R. Soc. Interface 7 Suppl. 1 2010 S67 S82 10.1098/rsif.2009.0260
191. D.R. Zimmermann, and M.T. Dours-Zimmermann Extracellular matrix of the central nervous system: from neglect to challenge Histochem. Cell Biol. 130 2008 635 653 10.1007/s00418-008-0485-9
192. E. Syková, and C. Nicholson Diffusion in brain extracellular space Physiol. Rev. 88 2008 1277 1340 10.1152/physrev.00027.2007
193. G.D. Kenny, A.S. Bienemann, A.D. Tagalakis, J.A. Pugh, K. Welser, F. Campbell, and et al. Multifunctional receptor-targeted nanocomplexes for the delivery of therapeutic nucleic acids to the Brain Biomaterials 34 2013 9190 9200 10.1016/j.biomaterials.2013.07.081
194. E.A. Nance, G.F. Woodworth, K.A. Sailor, T.-Y. Shih, Q. Xu, G. Swaminathan, and et al. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue Sci. Transl. Med. 4 2012 149ra119 10.1126/scitranslmed.3003594
195. P.A. Netti, D.A. Berk, M.A. Swartz, A.J. Grodzinsky, and R.K. Jain Role of extracellular matrix assembly in interstitial transport in solid tumors Cancer Res. 60 2000 2497 2503
196. C.-H. Heldin, K. Rubin, K. Pietras, and A. Ostman High interstitial fluid pressure - an obstacle in cancer therapy Nat. Rev. Cancer 4 2004 806 813 10.1038/nrc1456
197. A. Pluen, Y. Boucher, S. Ramanujan, T.D. McKee, T. Gohongi, E. di Tomaso, and et al. Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors Proc. Natl. Acad. Sci. U. S. A. 98 2001 4628 4633 10.1073/pnas.081626898
198. R.K. Jain, and T. Stylianopoulos Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 7 2010 653 664 10.1038/nrclinonc.2010.139
199. I. Beyer, Z. Li, J. Persson, Y. Liu, R. van Rensburg, R. Yumul, and et al. Controlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumab Mol. Ther. 19 2011 479 489 10.1038/mt.2010.256
200. T. Stylianopoulos, M.Z. Poh, N. Insin, M.G. Bawendi, D. Fukumura, L.L. Munn, and et al. Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions Biophys. J. 99 2010 1342 1349 10.1016/j.bpj.2010.06.016
201. R.G. Thorne, and C. Nicholson In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space Proc. Natl. Acad. Sci. U. S. A. 103 2006 5567 5572 10.1073/pnas.0509425103
202. E. Nance, K. Timbie, G.W. Miller, J. Song, C. Louttit, A.L. Klibanov, and et al. Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound J. Control. Release 189 2014 123 132 10.1016/j.jconrel.2014.06.031
203. E. Nance, C. Zhang, T.-Y. Shih, Q. Xu, B.S. Schuster, and J. Hanes Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration ACS Nano 8 2014 10655 10664 10.1021/nn504210g
204. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603 10.1126/science.8128245
205. P. Calvo, B. Gouritin, H. Chacun, D. Desmaile, J. D'Angelo, J.P. Noel, and et al. Long-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery Pharm. Res. 18 2001 1157 1166 10.1023/A:1010931127745
206. J. Morizet, G. Eve, and H. El Poly (ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting J. Pharmacol. Exp. Ther. 303 2002 928 936 10.1124/jpet.102.039669.thelial
207. A. Burgess, Y. Huang, W. Querbes, D.W. Sah, and K. Hynynen Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression J. Control. Release 163 2012 125 129 10.1016/j.jconrel.2012.08.012
208. K. Timbie, C. Burke, E. Nance, G. Woodworth, G.W. Miller, J. Hanes, and et al. Ultrasound-targeted delivery of systemically administered therapeutic nanoparticles J. Acoust. Soc. Am. 134 2013 4047 10.1121/1.4830769